ABSTRACT
This study evaluated whether the administration of 50 and 100mg bovine somatotropin (bST) at the start of synchronization and at the time of natural mating in ewes improves the ovulation rate, embryonic development and pregnancy rate of transferred embryos. Forty-eight donors were assigned to three treatments: the bST-100 treatment (n=15) received 100mg bST at the start of synchronization and at natural mating, the bST-50 treatment (n=15) received 50mg bST on the same schedule as the previous group, and the control (n=18) did not receive any bST. Two embryos were transferred to each recipient (n=121): 35 received embryos from bST-100; 50 received embryos from bST-50, and 36 received embryos from the control. The superovulatory rate, percentage of recovered structures, cleavage rate, percentage of transferable embryos, embryo quality and development and pregnancy rate were analyzed using the GENMOD procedure of SAS. The number of corpora lutea and the cell number were analyzed using the GLM procedure of SAS. The insulin and IGF-1 concentrations were analyzed with ANOVA for repeated measures. The bST application did not affect the superovulatory rate, number of corpora lutea and recovered structures (P>0.05). The numbers of transferable embryos and embryos reaching the blastocyst were higher (P≤0.01) in the bST-50 (96.4±3.6% and 69.0±7.8%) than the bST-100 (93.0±4.5% and 27.2±38.9%) and control (87.7±5.4% and 50.4±6.4%) groups. The insulin and IGF-1 concentrations were higher (P<0.05) in the bST-treated groups, but the insulin concentration was higher (P<0.05) in the bST-100 group than in the bST-50 group. The pregnancy rate was similar (P=0.21) in ewes receiving embryos from the two treatments [bST-50, (70.0%); bST-100, (62.5%), and control, (56.6%)]. The administration of 50mg bST at the start of synchronization and at natural mating in superovulated ewes was concluded to enhance the proportion and development of transferable embryos. However, bST did not affect the pregnancy rate of transferred embryos.
Subject(s)
Embryonic Development/drug effects , Growth Hormone/pharmacology , Sheep, Domestic , Superovulation/drug effects , Animals , Blastocyst/cytology , Cattle , Cell Count , Dose-Response Relationship, Drug , Embryo Transfer/veterinary , Estrus Synchronization/blood , Female , Insulin-Like Growth Factor I/metabolism , Pregnancy , Pregnancy Rate , Sheep, Domestic/embryology , Sheep, Domestic/physiology , Superovulation/bloodABSTRACT
Linfocitos humanos fueron irradiados en un campo de radiación gamma de baja intensidad para determinar la expresión de las proteínas de choque calórico en función de la dosis. Los linfocitos fueron obtenidos de individuos cuyo trabajo los identifica como ocupacionalmente expuesto y no ocupacionalmente expuestos. La identidad de las proteínas se realizó utilizando anticuerpos contra las proteínas Hsp25, Hsp60, Hsp70 y Hsp90. De éstas, solamente la proteína hsp70 fue detectada antes y después de la irradiación. Los linfocitos del personal ocupacionalmente expuesto y no ocupacionalmente expuesto expresaron, antes y después de la irradiación, solamente la proteína Hsp70. La cantidad de proteína resultó directamente proporcional al tiempo de irradiación. Después de una dosis gamma de 70.5 mGy, los linfocitos del individuo ocupacionalmente expuesto expresaron una mayor cantidad de proteína Hsp70 que la expresada por los linfocitos del personal no ocupacionalmente expuesto. Este hecho es indicio de que el individuo ocupacionalmente expuesto tiene una mayor tolerancia a los rayos gamma (gamma-tolerancia), inducida por un proceso de adaptación generada por su condición laboral
